Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Expression Market

Gene Expression Market Share

Report ID: GMI8370
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Gene Expression Market Share

The competitive landscape of the gene expression industry is characterized by the presence of established pharmaceutical companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective gene expression.

Gene Expression Market Companies

Prominent players operating in the gene expression industry are as mentioned below:

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
GE HealthCare Technologies, Inc.
Illumina, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of gene expression reached USD 12.5 billion in 2023 and is set to witness 7.1% CAGR from 2024 to 2032, led by technological advancements and a growing emphasis on personalized medicine.

The consumables segment accounted for 46.9% of the market share in 2023, owing to its steady and regular use in gene expression experiments which are typically tailored to specific techniques or platforms.

North America market is set to exhibit robust growth between 2024 and 2032, attributed to the increased funding from government agencies, private investors, and pharmaceutical companies in the region.

Some prominent firms operating in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen N.V., and Thermo Fisher Scientific Inc.